Advertisement
Home Tags Radiation

Tag: Radiation

Certain Prostate Drugs Tied to Risk for Parkinson Disease

Gabapentin May Cut Opioid Needs for Oral Mucositis Pain During RT

0

Findings seen in studies involving patients receiving chemoradiotherapy for nonmetastatic squamous cell carcinoma of head and neck

MRI image of human brain with red color marked focal lesion in the hospital room

Guideline Updated for Use of Radiation for Brain Metastases

0

Updated guideline discusses advanced radiation therapy techniques and places emphasis on multidisciplinary care

Use of Proton Beam Therapy for Newly Diagnosed Cancer on the Rise

0

Uptake of proton beam therapy for cancer treatment varies by clinical indication

Fear of Cancer Recurrence Prevalent in Patients

Racial Differences Seen for Use of Proton Beam Therapy

0

Disparities greatest most recently and for cancers for which PBT is the recommended radiation therapy modality

Thyroidectomy Without I-131 Noninferior in Low-Risk Thyroid Cancer

0

For patients with low-risk thyroid cancer undergoing thyroidectomy, follow-up without radioiodine noninferior to ablation with radioiodine

Less Toxicity Seen With MRI-Guided SBRT for Prostate Cancer

0

Rate of acute grade ≥2 genitourinary toxicity lower with MRI guidance versus CT guidance for SBRT in men with localized prostate cancer

Adding ADT to Radiotherapy Ups Mets-Free Survival in Prostate Cancer

0

In meta-analysis, adjuvant ADT prolongation also linked to improvement in metastasis-free survival, but not neoadjuvant ADT extension

Breast Cancer Survivors Face Higher Risk for Hypertension, Diabetes

0

Risk for hypertension even higher for those receiving left-sided radiation therapy, endocrine therapy

Guideline Issued for External Beam RT in Primary Liver Cancers

0

EBRT strongly recommended as potential first-line therapy for patients with HCC confined to liver who are not candidates for curative therapy

Unnecessary RT Given Near End of Life in Metastatic Cancer

0

Guideline-nonconcordant radiotherapy given to substantial proportion of Medicare beneficiaries with metastatic cancer near the end of life